Compensation Overview

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit high-value frontier targets in RAS-addicted cancers.  The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding scientists in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

To aid in this mission, the Translational Medicine (TM) team at RevMed is seeking a highly motivated, scientifically creative, and collaborative Associate Director to work in a fast-paced environment within a cross-functional team. This role will be the Translational Medicine lead for companion diagnostic (CDx) development for RAS(ON) inhibitors across different solid cancer types. Activities will be centered around analytical and clinical validation of CDx tests to support global regulatory submissions.

Responsibilities:

• Drive implementation of the CDx strategy to support early and late-stage development of portfolio assets.

• Lead or participate in joint project teams (JPTs) with diagnostic partners and internal cross-functional team members to ensure successful execution of analytical and clinical validation studies.

• Effectively collaborate with biomarker scientists, biomarker operations, clinical development, and clinical operations, to ensure successful collection and CDx testing of clinical trial samples.

• Collaborate closely with diagnostic partners and internal functions, including biostatistics, data management, medical writing, regulatory, and project management to enable regulatory submissions to support CDx approvals.

• In working with project management and finance, manage contracts, budgets, and timelines of key milestones associated with CDx development.

• Collaborate with clinical development and medical affairs to develop plans for publication of CDx test results in identifying biomarker-positive patient populations.

• Collaborate with commercial colleagues to develop strategies that enable access to CDx tests for launch readiness.

Required Experience, Skills and Education:

• A Ph.D. in cancer biology, cell/molecular biology, genomics or equivalent with 6+ years of industry experience.

• 2+ years of experience in CDx development is required.

• Broad knowledge and understanding of established and novel technologies employed in clinical diagnostic assays (e.g. NGS, IHC, PCR) are required.

• Excellent scientific and business communication skills, strong interpersonal/collaboration skills and planning skills.

• Ability to think critically and creatively and be able to work independently to determine appropriate resources for resolution of problems.

• Ability to multi-task and thrive in a fast-paced innovative environment.

• A great teammate, who listens effectively and invites response and discussion.

• Commitment to Revolution Medicines’ Core Values: Tireless Commitment to Patients, Transformative Science, Exceptional Together, Total Integrity, Inclusiveness and Fairness.

The expected salary range for this role is $175,000 to $210,000.  An individual’s position within the range may be influenced by multiple factors, including skills and experience in role, overall performance, individual impact and contributions, tenure, and market dynamics. Base salary is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.

Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition and veteran status.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].